Nā Luʻi Analytical Peptide Macrocyclic: He alakai hooikaika

Pane wikiwiki

Why macrocyclic peptide analytical challenges decide deal diligence: purity profiling, structural confirmation, impurity mapping, solubility and stability.

No ke aha e hoʻoholo ai nā pilikia analytical macrocyclic peptide inā e ola ana kahi kuʻikahi me ka ikaika

he elima pae kaulahao e hōʻike ana i ka maemae profiling hānai structural hōʻoia, a laila ʻano haumia, a laila hoʻoheheʻe, a laila kūpaʻa, me kahi

Ua hoʻolaha ʻia ka hui ʻana o Novartis a me Unnatural Products i Pepeluali 2026 hoʻokō i ka $100 miliona ma ka uku mua a me ka helu mua o ka IND, me kahi hou aku $1.7 billion pili i ka hoʻomohala ʻana, nā kūlana hoʻoponopono a me nā kālepa, he huina poʻomanaʻo o ka ʻoi aku $1.8 piliona (GEN, 2026). He lua, like like ka nui macrocycle collaboration ma hope o ia makahiki, ma waena o Novo Nordisk a me Orbis Medicines, lawe ʻia a $1.4 piliona poʻomanaʻo (ʻO Biotech Fierce, 2026). Both figures are headline totals that include contingent milestones, so they are not comparable cash values.

Nā Luʻi Analytical Peptide Macrocyclic: He alakai hooikaika

What transfers at signing is not the headline. Under the Novartis terms, Novartis will run IND-enabling work and everything after it, including clinical development, manufacturing and global commercialization (GEN, 2026). The asset that has to stand on its own is the analytical package, and five disciplines carry it in a fixed order: purity profiling, structural confirmation, ʻano haumia, hikiwawe, a laila kūpaʻa. Each depends on the one before it.

He aha ka mea e ʻokoʻa ai nā pilikia analytical macrocyclic peptide mai ka hana peptide linear

A macrocycle is a peptide whose backbone has been closed into one or more rings, and that ring is the reason the analytical work changes. Macrocyclic peptides are positioned as combining biologic-like selectivity with small-molecule-like properties, a dual profile that has drawn large partnership investment into the class (GEN, 2026).

Nā Luʻi Analytical Peptide Macrocyclic: He alakai hooikaika

Hoʻemi ka scaffold i hoʻopaʻa ʻia i ke kūʻokoʻa conformational. ʻO kēlā kaohi kahi i loaʻa mai ai ka pōmaikaʻi therapeutic, a ʻo ia hoʻi kahi e hoʻomaka ai ka pilikia analytical: ʻO ka liʻiliʻi o nā conformations hiki ke loaʻa, ʻo ia hoʻi, ʻaʻole hiki ke ʻike hou ʻia ke ʻano o ka mole i ka hoʻokaʻawale ʻana a i ʻole ka spectrometer nuipaʻa mai ke kaʻina laina i kūkulu ʻia mai..

ʻElua hopena ma hope, a hana lākou i kēlā me kēia ʻāpana ma lalo. Ka mua, ʻaʻole ʻo ka nui paʻa pono e hōʻoia i ka pani ʻana o ke apo; haʻi ka nuipa iā ʻoe i ka haku mele, ʻaʻole ka topology. Ka lua, ʻoi aku ka laulā o nā papa haumia ma kahi ala macrocycle ma mua o nā papa laina laina, no ka cyclization, hana alahaka, a ʻo ke kemika pūʻulu pale a puni lākou e hāʻawi i kā lākou huahana ponoʻī.

E mālama i ke apo, ʻaʻole ke kaʻina, e like me ka mea analytical.

ʻO ka hoʻomaʻemaʻe profiling: no ke aha i hāʻawi ʻole ai ka pākēneka HPLC hoʻokahi i nā piko

Hoʻomaka ka hoʻomaʻemaʻe maʻemaʻe Macrocycle me kahi ʻokoʻa i hūnā ʻia kahi helu chromatographic hoʻokahi: ʻo ka pākēneka he pane ʻāpana pili, ʻaʻole kahi ʻōlelo o ka ʻike a i ʻole ka ʻike. Hoʻokaʻawale ʻo HPLC a i ʻole UPLC hoʻololi i nā ʻāpana a hōʻike i ka nui o nā mea hoʻoheheʻe UV i hoʻoheheʻe ʻia i kēlā me kēia pukaaniani.. ʻAʻole ia e haʻi iā ʻoe i ke ʻano o ia mau mea, ʻAʻole ia e haʻi iā ʻoe i ka nui o ka vial he peptide.

Hoʻokaʻawale ʻia ka ʻike peptide net mai ka maʻemaʻe chromatographic, ma ka hoʻokalakala elemental, ka nānā ʻana i ka waikawa amino a i ʻole ka spectrophotometry UV, a hāʻule maʻamau i waena 60% a 90% o ka nui o ka peptide kaumaha, me nā counterions a me ka wai e hana i ke koena (ʻO Ambiopharm, lā ʻole, kiʻi ʻia 2026-06-11). ʻO kahi palapala hōʻike hōʻike no ka nānā ʻana e hōʻike ana i ke āpau: HPLC maemae 98.7% me ka peptide maʻiʻo 76.4%, wai 6.2% a me ka counterion 15.8% (Maʻemaʻe Peptides, lā ʻole; laʻana ʻaoʻao ʻekolu, ʻaʻole he kiʻi pūnaewele i hōʻoia ʻia).

He mea nui ka palena ma mua o ka helu. Hoʻokahi pākēneka maʻemaʻe RP-HPLC ʻaʻole i hāʻawi i nā piko a ʻaʻole hiki ke hoʻokaʻawale i kahi kaʻina i ʻoki ʻia mai kahi regioisomer i hoʻololi pono ʻia i ka puka aniani hoʻokahi.. ʻO ka mea i makemake ʻia e ka mea hoʻomaʻamaʻa ikaika ʻo ia ka hana kiʻekiʻe: i hui pū ʻia nā piko, ka mea i ʻike ʻia kēlā me kēia, a ma ke ʻano hana orthogonal.

Hōʻoiaʻiʻo: e hōʻoia ana i ka pani ʻana o ke apo a me ke ʻano alahaka, ʻaʻole nuipa nominal

ʻelua mau ʻano macrocyclic me ke ʻano molekala like ʻole a me ka nui paʻa like, ʻokoʻa wale nō ka mea i hoʻopaʻa ʻia ke koena paʻa i ka pani apo, wi

ʻO ka nuipa paʻa i kūlike i ka waiwai i manaʻo ʻia e hōʻoia i ka haku mele ʻana, ʻaʻole topology. Hiki i ʻelua macrocycles ke kaʻana like i ka molecular formula, he nuipaʻa paʻa like, a me ka pili apo okoa loa, no laila ʻo ka macrocyclic peptide structural confirmation pono e pane i kahi nīnau lehulehu wale ʻaʻole hiki: ʻo nā koena e pani maoli i ke apo, a ma ke ano o ke alahaka.

ʻO ke ʻano hāʻule ʻana he paʻa. Hiki i ke poʻo a ka huelo cyclization a me ka ʻaoʻao-chain-to-side-chain alahaka hiki ke hana i ka nui inoa like ʻoiai ke kau ʻana i ke kaohi macrocyclic ma nā ʻāpana like ʻole o ka scaffold.. ʻO kēlā mau molekala ʻelua he regioisomers, a ʻokoʻa ko lākou ʻano i ka hoʻopaʻa ʻana i nā mea hoʻokipa, i ka paʻa chromatographic, a i ke kupaa. ʻO kahi nui paʻa pololei me kahi regioisomer i hoʻoholo ʻole ʻia he hoʻoholo hoʻokuʻu i hana ʻia ma nā hōʻike piha ʻole..

Hoʻopili ka Epimerization i ka pilikia, a ka hōʻike pilikia epimerization i hōʻike ʻia e Bachem wehewehe i ke kumu he nīnau hoʻolālā ma mua o ka nīnau maʻemaʻe. ʻO ka hoʻokumu ʻana i kahi mea waena oxazolone e hoʻokuʻu i ka α-carbon racemize, a piʻi ka pilikia me ka lōʻihi o ka manawa hoʻāla, nā mea hoʻopili hoʻopaʻapaʻa, ka hōʻiliʻili ʻana o nā mea waena, a me ka wela kiʻekiʻe. Hoʻomaopopo ke kumu like i ka phenylglycine, ʻo ka cysteine, histidine, a ʻo nā koena me nā kaulahao ʻaoʻao e hoʻihoʻi i ka electron ʻoi aku ka epimerization-prone. ʻO ke koena D ma kahi kūlana hoʻokahi e hoʻololi i ke ʻano ʻekolu-dimensional me ka hoʻololi ʻole i ka nuipaʻa.

ʻElua mau ʻenehana e lawe i ka hana hōʻoia, a he palena kūpono ko kēlā me kēia me ka wehewehe pono. Hoʻoholo ka tandem mass spectrometry i ke kaʻina a me, me ka uhi ʻana i nā ʻāpana ʻāpana kūpono, hiki ke hoʻokaʻawale i kahi e noho ai kahi alahaka, akā, pili ka uhi i ke ʻano o nā ʻāpana scaffold i kāohi ʻia, a ʻo kahi macrocycle i ʻāpana maikaʻi ʻole e waiho i nā āpau i kahi e pono ai ka pane. Hoʻoholo pololei ʻo NMR i ka pilina a me ka stereochemistry, me ka pani ʻana i ke apo a me ka hāʻawi ʻana i ke alahaka, akā, ʻo kona mau palena sensitivity ʻo ia ka haʻahaʻa haʻahaʻa haʻahaʻa hiki ke waiho i ka hoʻokolohua ma waho o ka hiki. ʻAʻole lawa nā ala ponoʻī no kēlā me kēia scaffold.

ʻano haumia: ka palapala ʻāina i ka mea e hana maoli ai ke ala

ʻO ka hoʻohālikelike ʻana i ka haumia peptide he mea hiki ke hāʻawi ʻia, ʻaʻole he QC ma hope o ka manaʻo: Pono ka palapala 'āina haumia e kapa i nā huahana i hiki i ke ala synthetic ke hana maoli, a ʻo ke ala e hoʻoholo ai i nā mea e manaʻo ai. Hoʻopaʻa maikaʻi ʻia nā kumu aspartimide-prone. Wahi a ʻO ka manaʻo nui o Bachem o ka hui, racemization a me nā ʻaoʻao ʻaoʻao i ka solid-phase peptide synthesis, ʻO ka hoʻokumu ʻana o ka aspartimide ka mea maʻamau i nā peptides i loaʻa iā Asp-Gly, ʻO nā kaʻina Asp-Ala a i ʻole Asp-Ser, hiki ke loaʻa ma lalo o nā kūlana acidic a kumu paha, a wehe hou e hāʻawi i ka hui ʻana o α- a me nā peptides pili β; i ka hoʻohui Fmoc, Hiki i ka piperidine ke wehe i ka aspartimide e hoʻohua i ka piperidides (2019). ʻO ka hoʻokumu ʻana o Diketopiperazine kahi pilikia dipeptide-stage, ʻoi aku ka nui ma ka synthesis e pili ana i ka Fmoc a ʻoi aku ka nui inā ʻo proline kekahi o nā koena mua ʻelua, me HOBt i hoʻohui ʻia i ka piperidine deprotection solution e like me ka mitigation i ʻōlelo ʻia (peptide.com, 2019). ʻO ka epimerization kumu i ka wā deprotection kahi kekona, alahele ʻokoʻa: ʻO ka ʻaoʻao kikowaena ʻike a Bachem e pili ana i ka pilikia epimerization e pili ana i nā kumu ikaika, nā kūlana deprotection koʻikoʻi a me ka hōʻike kumu lōʻihi, a wehewehe i ke ala aspartimide/glutarimide i ka wā e hui ai nā kumu like me Asp-Gly i nā kūlana kumu a me ka wela. (2026). ʻO nā loiloi hou o nā huahana pili i ka aspartimide e mālama i ka papa ma ke ʻano he pilikia hoʻolālā i wehewehe ʻia me nā mīkini ʻike a me nā hoʻolālā pale. (Aucagne et al., 2025).

ʻO ka peptide Nucleic Acid Synthesis ʻOi aku ka laulā o ka hoʻonohonoho piha i ka noi ma mua o kēlā mau ʻekolu: koena laina mua, nā kaʻina i ʻoki ʻia, epimers, nā oligomer a me nā hui, me nā huahana oxidation a me deamidation. No ka macrocycle, ʻO ke koena linear precursor ka mea nui loa, no ka mea, ʻo ia ka ʻano i like loa me ka huahana ma ka helu helu helu-nui.

Ki Takeaway: ʻAʻole hiki ke ʻike ʻia kahi hōʻike nominal-mass release i nā huahana aspartimide, epimers, a i ʻole ka laina mua. E koi i nā ʻano hana orthogonal i hiki: chromatographic Spps Peptide Synthesis ka hookaawale ana i na mea pili, kiʻekiʻe-resolution mass spectrometry, a, kahi i nīnau ʻia ai ka topology, nā ʻenehana hana i uhi ʻia ma ka pauku mua.

ʻO ka handoff analytical-to-purification kahi e uku ai kēia hana nona iho. Ua hoʻomohala ʻia nā kūlana hoʻokaʻawale e hoʻoholo i ka palapala ʻāina haumia i ke kumu no nā kūlana hoʻomaʻemaʻe chromatographic nui., no laila, ʻo ke ʻano haumia i kūkulu ʻia no ka hele ʻana i kahi kikoʻī e hoʻopau i ka hoʻoholo i loaʻa mua.

Ka hoʻoheheʻe a me ka hoʻohui: ka pilikia hiki ke hoʻololi i ka hoʻolālā assay

Gku Me na Peptides Aia ka hana hoʻonā i ka pūʻolo hōʻailona mua, ʻaʻole i loko o kahi faila formulation i wehe ʻia he ʻumikumamāwalu mahina ma hope. ʻO ka hui ʻana ke kumu: ʻAʻole hiki ke wānana hilinaʻi ʻia mai ka ʻikepili kaʻina, e like me ka peptide.com's 2019 ka nānā ʻana i nā ʻaoʻao ʻaoʻao synthesis solid-phase. ʻOi aku ka maʻalahi o nā kaʻina hydrophobic, a ʻo ka loiloi hoʻokahi e waiho i ka puka makani lōʻihi kaulahao ma kahi o ka ʻelima a i ʻole ke ono o ke koena a hiki i ka iwakāluakūmākahi., ʻo ia ka pūʻulu lōʻihi e noho ai ka hapa nui o nā moho lāʻau macrocyclic.

Loaʻa i kēlā unpredictability nā hopena hana ʻelua. Ka mua, Hiki ke hoʻokaʻawale ʻia kahi ʻano ʻano hui like me kahi kiʻekiʻe ākea a hoʻololi paha, no laila, ʻaʻole hiki ke hoʻololi ʻia kahi ʻano hoʻomaʻemaʻe i kūkulu ʻia ma ke ʻano monomeric. Ka lua, a emi pinepine ka manao, hoʻololi ka hui ʻana i nā kūlana i ana ʻia ai ka maʻemaʻe ponoʻī: pale, mahana wela, a hiki i ka noʻonoʻo ke hoʻoneʻe i ka hopena i ʻike ʻia me ka ʻole o ka hoʻololi ʻana i ka mea.

Hoʻohui ʻia ka heterogeneity conformational i loko o kahi scaffold i hoʻopaʻa ʻia. Hiki i ka macrocycle ke hoʻonui i ka hoʻohālikelike hoʻonā, a hiki i kēlā me kēia mea ke launa like ʻole me ka pae paʻa, No laila, hōʻike ka hana chromatographic i ka hui conformational ma mua o kahi ʻano i wehewehe ʻia.

No laila, ʻo ka noi kūpono ʻo ia ka ʻikepili hoʻonā mua, hana ʻia ma lalo o nā kūlana i ʻōlelo ʻia, ma mua o ka hoʻonui ʻana i ka hoʻomaʻemaʻe ʻana a ma mua o ka laka ʻana o nā kūlana hoʻāʻo.

Paʻa: ka hoʻolālā ʻana i nā ala e hōʻike ai i ka paʻa i ka hoʻomaka ʻana o ka papahana

he laina manawa e hoʻohālikelike ana i ʻelua ala papahana: kahi e hoʻomaka ai ka hoʻolālā ʻana i ke ʻano paʻa i ka hoʻomaka ʻana o ka papahana a ʻo kahi hoʻi e hoʻomaka ai ma ka pae hope

ʻO ka paʻa ʻana o ka peptide macrocyclic kahi hoʻoholo hoʻolālā, ʻaʻole he hana mālama ola. ʻO ke ala hoʻokuʻu i hoʻopaʻa ʻia e pili ana i ka kikoʻī e hōʻoia i ka hoʻokō ʻana o kahi pūʻulu i kahi palena i wehewehe ʻia; he ʻano hōʻike kūpaʻa Peptide 1 pono e hoʻoholo i nā huahana degradation i hana ʻia i ka manawa a hoʻokaʻawale iā lākou mai ka piko makua, ʻo ia ke kumu i hoʻolālā ʻokoʻa ai nā mea ʻelua a no ke aha ʻaʻole hiki ke hoʻihoʻi hou ʻia ka lua.

He mea koʻikoʻi kēlā ʻokoʻa no ka hoʻohaʻahaʻa ʻana o nā macrocycles ma o nā ala like. ʻO nā hoʻolālā kūpaʻa peptide i loiloi ʻia i loko o ka palapala uhi hydrolysis, oxidation, a me ka epimerization, me ka hoʻololi ʻana i ka iwi kuamoʻo a me ka hoʻololi ʻana i ka waika D-amino ma waena o nā hoʻololi hoʻololi i hoʻohana ʻia e hoʻolōʻihi iā lākou (Al Musaimi et al., 2022). ʻAʻole ʻike ʻia kahi ʻano hana i kūkulu ʻia i ka palena hoʻokuʻu wale ʻana i kahi epimer co-eluting a i ʻole kekahi ʻano mea i hoʻoheheʻe ʻia e ulu ana ma ka waiho ʻana..

Hoʻopili pololei ke koho ala synthesis i ka mea e hoʻoholo ai ke ala. Ma hoʻokahi pahuhopu agonist GLP-1 oi aku 40 nā pōʻaiapuni, ua hōʻike ʻia ka ʻaoʻao pilikia epimerization i hōʻike ʻia e Bachem 13% hoʻokumu ʻana i ka epimer ma kahi ala ʻāpana, a ua hoopauia ke alahele; ua hōʻike ʻia kahi ʻāpana ʻāpana ʻelua i kahi ʻaoʻao epimerization ʻē aʻe, ma 2 i 3% i ka palaka, e piʻi aʻe ana 5% mahope o ka hoomaemae ana, ʻoiai ua pale aku ka linear SPPS i nā pilikia epimerization ma kēia pahuhopu a hāʻawi i ka hopena kiʻekiʻe loa (Bachem, 2026).

[VISUAL: ʻO ke kiʻikuhi kaʻina hana e hoʻohālikelike ana i ʻelua ala papahana. Hoʻonohonoho ʻo Ala hoʻokahi i ka hoʻolālā ʻana i ke ʻano hoʻolālā i ka hoʻomaka ʻana o ka papahana, ma mua o ka hoʻokuʻu ʻana. Hoʻokomo ʻia ke ala ʻelua i ka hoʻāʻo ʻana i ke ola o ka papa, me ka puka hana hou e hoʻi ana i ka hoʻomohala ʻana i ke ʻano i ka wā i ʻike ʻia ai nā huahana degradation ʻaʻole hiki i ke ʻano hoʻokuʻu ke hoʻoholo.]

No laila, ʻo ke koi pono no kahi pūʻolo hoʻoikaika ʻia he moʻolelo i hoʻopaʻa ʻia i ka wā i hoʻolālā ʻia ai ke ʻano hōʻike kūpaʻa, he aha nā kūlana hoʻohaʻahaʻa ikaika i hoʻohālikelike ʻia, a inā paha e hoʻokaʻawale i ka epimer a me nā huahana oxidation i ʻike ʻia ke ala i koho ʻia e hana.

ʻO nā manaʻo kuhihewa maʻamau i nā pilikia analytical peptide macrocyclic

Elima hewa heluhelu hou i loko o ka ho'oikaika 'ana i nā loiloi, a hoʻi kēlā me kēia mea i kahi mīkini ma mua o ka hemahema o ka mea kūʻai aku.

ʻAʻole hōʻoia ʻia ka paʻa ʻana o ke apo i kahi nui paʻa pololei. Hōʻike ka mass spectrometry i ka hui ʻana o ka mole, no laila he laina mua, he hua paikalakala poo-to-tail, a hiki i ka regioisomer i hoʻopaʻa ʻia me ke kaulahao ʻaoʻao ke hoʻihoʻi i ka nuipa inoa like. Pono ka topology i nā hōʻike orthogonal: mokuahana e pili ana i ke alahaka, a i ʻole NMR kahi e ʻae ai ka nuipaʻa hāpana. Fmoc Peptide Synthesis

ʻAʻole hoʻokumu ka pākēneka hoʻomaʻemaʻe HPLC kiʻekiʻe i ka ʻike peptide. ʻO ka maʻemaʻe kahi ana pili o ka wahi kiʻekiʻe e kū'ē i nā mea ʻē aʻe e hoʻoheheʻe ʻia ma ia ʻano, no laila hiki i ka chromatogram ke heluhelu 98 pakeneka ʻoiai ʻo ka ʻiʻo peptide maoli, ana ʻia e ka nānā ʻana i ka waikawa amino a i ʻole UV, noho haahaa. Kūʻē, wai koena, a ʻaʻole ʻike ʻia nā paʻakai i ka helu maʻemaʻe.

ʻAʻole pilikia ka hoʻoheheʻe ʻana i ka pae hana. ʻO ka hui ʻana a me ka hoʻoheheʻe maikaʻi ʻole e hoʻololi i ka hoʻolālā assay, laʻana hana, a me ka pono o nā ʻano hana i hoʻohana ʻia e hana i ka ʻikepili mua.

ʻAʻole hoʻomaʻamaʻa ʻo ke kūpaʻa. ʻAʻole hiki i kahi ʻano hana i hōʻike ʻole ʻia he kūpaʻa - ʻaʻole hiki ke hoʻokaʻawale i kahi huahana degradation mai kahi hana haumia., a ʻo kēlā ʻokoʻa ka mea a ka mea loiloi e ʻimi nei.

ʻO ka kūleʻa o ka Synthesis ka helu komo i ka hana analytical, ʻaʻole ka laina hoʻopau.

Ke kūkulu ʻana i ka pūʻolo hōʻike hōʻike loiloi maoli ka mea kūʻai aku

ʻAʻole loaʻa i nā pūʻulu ikaika nā ʻōlelo hiki ke helu. Loaʻa lākou i nā ʻikepili kikoʻī he nui, no ka mea e wehewehe ana kahi ʻōlelo i ka mea a ka mea hoʻolako e ʻōlelo ai e hiki iā ia ke hana aʻo kahi palapala hōʻoia e wehewehe ana i ka mea i loaʻa i ka mea i mua o lākou. ʻO ka hoʻāʻo pono inā ʻae nā palapala i kahi loiloi kūʻokoʻa e kūkulu hou i ka hopena.

Loaʻa i kahi pūʻolo piha no kahi peptide macrocyclic kahi palapala hōʻoia no ka nānā ʻana, ka HPLC chromatogram ma hope o ka maʻemaʻe i hōʻike ʻia, a me ke kiko nui ma hope o ke kelepona ʻike, me nā kūlana hana hiki ke ʻimi ʻia mai ka hoʻomohala ʻana i ka hoʻomohala ʻana a hiki i ka pae hoʻomākaukau. Pono ka ho'āʻo hoʻokuʻu e hoʻohana i nā ʻenehana hoʻohui i ka hoʻāʻo a me ka maʻemaʻe e HPLC a i ʻole UPLC, no ka mea ʻaʻole hiki i kahi ʻano hoʻokaʻawale hoʻokahi ke hōʻoia i ka mea i hoʻoholo ʻole ʻia. Peptide 1

Hoʻohana ʻo MOL Changes i kahi peptide R i hoʻohui ʻia&D anuu me ka Papa 100 hana hoʻomaʻemaʻe ultra-sterile, QC uhi MS, HPLC, ka nānā ʻana i ka ʻakika amino, endotoxin, kūʻē, ka hoʻololi ʻana a me ka ʻike UV, a hoopuka i kahi CoA, chromatogram a me MS spectrum no ka hailona ma na unahi mai mg a i kg.

Hōʻike: Loaʻa i ka MOL Changes kahi hoihoi pāʻoihana i nā kūlana maikaʻi peptide. ʻO ka ʻōnaehana hōʻike hōʻike ma luna nei he ʻano hana hoʻoikaika maʻamau, ʻaʻole he koi e pili ana i ka solubility a i ʻole nā ​​​​lawelawe kūpaʻa.

Nā ʻanuʻu aʻe: he aha ka mea e koi ai mai kahi hoa hana

ʻO ke ala wikiwiki loa e loiloi i kahi hoa hana no nā pilikia analytical macrocyclic peptide e nīnau i ʻehā mau nīnau a hoʻolohe i nā kikoʻī ma mua o nā hōʻoia..

Ka mua, e noi i ka palapala ʻāina haumia a me ke ala i hele mai ai. He hoa e hiki ke inoa i ka mea haumia i ke ala synthesis e hana ai, a ma kahi e ala mai ai, ke hana nei mai kāu kemika ma mua o ka la'ana. Ka lua, e nīnau i ke ala e hōʻoia ai i ka topology ma mua o ka nuipa. Inā kū ka pane i ka nuipaʻa paʻa, ʻAʻole i hōʻoia ʻia ka pani ʻana o ke apo a me ke ʻano alahaka. Ke kolu, e nīnau i ka wā i hoʻolālā ʻia ai ke ʻano hōʻike kūpaʻa. He ala i kūkulu ʻia i ka hoʻomaka ʻana o ka papahana, ma mua o ka hoʻohaʻahaʻa ʻia, ʻokoʻa ke ʻano mai ka mea i hoʻopaʻa hou ʻia ma hope o ka hiki ʻole ke kūpaʻa. Ka ʻehā, e noi i ka ʻikepili kikoʻī hailona ma mua o ka hailona hōʻike. ʻO kahi chromatogram mai kahi pūʻulu hōʻoia e haʻi iā ʻoe e pili ana i kēlā pūʻulu, ʻaʻole pili iā ʻoe.

Kākoʻo ʻo MOL Changes i kēia ʻano hoʻoikaika me kēlā me kēia-lot CoA, HPLC chromatogram, a me nā palapala kikoʻī MS, a me ka HPLC analytical, nuipaʻa spectrometry, a me ka nānā ʻana i ka ʻakika amino ma waena o ka paona mg a i kg. Inā makemake kāu polokalamu i kahi hoa hiki ke hele i kēia mau nīnau e kū'ē i kāu ala, e kamaʻilio me kahi loea e pili ana i kāu pūʻolo kikoʻī.

Nīnau pinepine

Pehea ka ʻokoʻa o nā pilikia analytical macrocyclic peptide mai ka hana peptide linear?

ʻO ka ʻokoʻa nui loa ʻo ia ka wehe ʻana o ka scaffold i ka manaʻo e hilinaʻi ʻia nā ʻano laina laina. ʻO ke kaʻina o ka peptide linear e wānana maʻemaʻe i kāna ʻano chromatographic a me nā ʻāpana ma MS / MS., ʻoiai ka pani ʻana o ke apo macrocycle, ʻano alahaka, a ʻo ka hoʻololi ʻana o ka conformational, ʻo ia hoʻi, ʻelua mau mole me ka nui like e hiki ke hana ʻokoʻa ma ke kolamu a ma ka pae kinoea.. Maemae, ʻike ʻike, a no laila pono ka hana haumia i kūkulu ʻia no ka macrocycle, ʻaʻole i hoʻololi ʻia mai kahi hoʻohālike laina.

Hiki i ka intact mass wale ke hōʻoia i kahi macrocycle?

ʻAʻole. ʻO ka nuipaʻa paʻa pololei e hōʻoiaʻiʻo i ke ʻano mole, ʻaʻole ka topology. ʻAʻole hiki ke hoʻokaʻawale i kahi apo i pani pono ʻia mai kahi laina mua, he regioisomer i kuhi hewa ʻia, a i ʻole kekahi ʻano alahaka ʻē aʻe me ka haku like. Pono ka hōʻoia ʻana o kahi macrocycle i nā hōʻike orthogonal e like me ka ʻikepili ʻāpana, NMR, a i ʻole nā ​​ʻimi noiʻi enzymatic a i ʻole kemika e hōʻike pono ana i ka pani ʻana o ke apo.

No ke aha i ʻokoʻa ai ka maʻemaʻe HPLC a me ka ʻike peptide?

ʻO ka hoʻomaʻemaʻe HPLC e ana i ka nui o nā mea e hoʻopaʻa ai i ka UV ma nā piko, ʻoiai ʻo ka ʻikepili peptide e ana i ka nui o ka hāpana he peptide maoli. Kūʻē, wai koena, nā paʻakai, a me nā mea haumia UV-hamuʻu e hāʻawi i ka nui akā ʻaʻole i ka chromatogram, no laila hiki i kahi pākēneka HPLC kiʻekiʻe ke noho pū me kahi ʻike peptide haʻahaʻa. ʻO ka nānā ʻana i ka waikawa amino a i ʻole ka ʻike peptide i hoʻokumu ʻia i ka UV e pani i kēlā āpau.

I ka manawa hea e hoʻolālā ʻia ai nā ʻano hana hōʻike kūpaʻa?

I ka hoʻomaka ʻana o ka papahana, ʻaʻole i ka hoʻomohala hope loa. ʻO kahi ala e hōʻike ai i ke kūpaʻa e hoʻoholo i nā huahana degradation i hana maoli ʻia e ka mole, a no ka macrocycle hiki iā lākou ke komo i nā ʻano mea i wehe ʻia, nā alahaka isomerized, a me nā hui. ʻO ka hoʻolālā ʻana i ke ʻano i ka wā i laka ʻia ai ke ala a me ka hoʻokumu ʻana, ʻo ia hoʻi ka hōʻoia hou ʻana i ka lohi, ke pipiʻi nā loli.

Hiki ke wānana ʻia ka solubility mai ke kaʻina?

ʻAʻole hilinaʻi no nā macrocycles. Ua kūkulu nui ʻia nā mea wānana e pili ana i ke kaʻina ma nā peptides linear, a pili ka solubility o ka macrocycle i ke ʻano o ka hōʻike ʻana o ka scaffold i hoʻopaʻa ʻia i kona mau kaulahao ʻaoʻao, ma ka aggregation propensity, a ma ka palapala counterion. Hoʻokumu maikaʻi ʻia ka solubility ma ka empirically, kakahiaka nui, me ka ho'āʻo i hoʻolālā ʻia a puni ka ʻano hoʻohui o ka mole.

Ka hopena

ʻO nā pilikia analytical peptide macrocyclic ke kumu hoʻoikaika ma hope o kēlā me kēia poʻomanaʻo, a ʻo ka pūʻolo hōʻike ka mea a ka mea kūʻai aku e loiloi maoli ai. Hoʻokumu ʻia nā ʻelima aʻoaʻo ma luna o kekahi i kekahi i kahi hoʻonohonoho paʻa: Hoʻokumu ka hoʻomaʻemaʻe profiling i ka mea i loko o ka hāpana, hōʻoia ka hōʻoia ʻana i ka scaffold a me ke alahaka ʻaʻole hiki i ka nuipa inoa, ʻO ke ʻano o ka haumia ka palapala ʻāina i ka mea i hana maoli ʻia e ke ala synthetic, ʻO ka hoʻoheheʻe a me ka hana hoʻohui e hoʻoholo inā paʻa ka hoʻolālā assay i nā ʻano kūpono, a me nā ʻano hana hōʻike kūpaʻa e lawe i ka papahana a hiki i ka hoʻokuʻu ʻana. Hoʻokuʻu i kahi ʻanuʻu a hoʻomaha nā mea hope ma ka manaʻo ʻaʻole hiki i ka mea loiloi ke nānā.

E manaʻolana e paʻa nā manaʻolana i ka neʻe ʻana o nā polokalamu macrocycle i ka hana IND, kahi e noi ai nā mea hoʻoponopono a me nā hoa pili i ke ʻano kikoʻī, ʻikepili pākahi-nui, a me nā palena i ʻōlelo ʻia ma mua o nā pākēneka hōʻuluʻulu. ʻO ke kaʻina hana aʻe, ʻo ia ke nīnau i kahi hoa hōʻike i ka mea a lākou e ana, pehea lākou i palapala ai, a kahi i pau ai ka hoʻoholo ʻana o kā lākou mau hana.

Miao He

Miao He

ʻepekema noiʻi ma nā ʻōnaehana hoʻouna Kaʻike kumu: Hāʻawi peptide waha, lipid nanoparticle (LNP) hoʻopili ʻana, nā peptides komo i loko o ke kelepona (CPPs), a me nā hoʻopuka hoʻokuʻu mau.

Pilikino: ʻO nā luʻi nui i ka hoʻomohala ʻana i nā lāʻau peptide aia i loko o ko lākou mau hapalua ola pōkole a paʻakikī me ka hoʻokele waha, a ʻo Miao ʻO ia kekahi loea alakaʻi i ka hoʻoponopono ʻana i kēia mau pilikia. Loaʻa iā ia ka ʻike nui ma ke kahua o nā ʻōnaehana lawe peptide. Ke hoʻomau nei ʻo ia i ka hoʻomohala ʻana i nā mea hoʻonui permeation novel a me nā nanospheres e hoʻomaikaʻi nui i ka bioavailability o peptides..

ʻIke ʻia & Nā alakaʻi hoʻoponopono
Nānā ʻia e: Ka poe akamai kumuhana
Kaʻana like i kēia ʻatikala
Home Huli Whatsapp Nā lawelawe Huahana